| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,588,676 |
|
|
|
Indirect Value
|
$4,891,842 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,480,518 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,833 |
43,148 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-07-15 |
4 |
D |
$224.33 |
$4,489,068 |
D/D |
(20,011) |
50,239 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-02-12 |
4 |
AS |
$20.02 |
$420,420 |
D/D |
(21,000) |
1,013,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
85,256 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
70,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,339 |
44,874 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,341 |
75,715 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-08-31 |
4 |
B |
$2.14 |
$48,227 |
D/D |
22,188 |
23,188 |
2.39 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-10-30 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
1,174,415 |
2.81 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-09-24 |
4 |
S |
$16.85 |
$421,250 |
D/D |
(25,000) |
1,561,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-10-01 |
4 |
AS |
$17.86 |
$446,500 |
D/D |
(25,000) |
1,536,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-01 |
4 |
AS |
$14.14 |
$366,400 |
D/D |
(25,000) |
1,511,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-05-01 |
4 |
AS |
$19.75 |
$493,750 |
D/D |
(25,000) |
1,248,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-06-03 |
4 |
AS |
$19.61 |
$490,250 |
D/D |
(25,000) |
1,223,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-12-27 |
4 |
AS |
$18.25 |
$456,250 |
D/D |
(25,000) |
1,090,531 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-15 |
4 |
AS |
$20.39 |
$509,750 |
D/D |
(25,000) |
1,063,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-22 |
4 |
AS |
$19.75 |
$493,750 |
D/D |
(25,000) |
1,038,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-15 |
4 |
AS |
$18.31 |
$457,750 |
D/D |
(25,000) |
913,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
AS |
$327.76 |
$8,719,378 |
D/D |
(26,124) |
28,265 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2014-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
29,412 |
1,303,827 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-01-02 |
4 |
AS |
$19.64 |
$783,715 |
D/D |
(39,904) |
1,403,127 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-12-03 |
4 |
AS |
$21.16 |
$846,400 |
D/D |
(40,000) |
1,456,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-02-01 |
4 |
AS |
$23.53 |
$941,200 |
D/D |
(40,000) |
1,363,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-03-01 |
4 |
AS |
$22.66 |
$906,400 |
D/D |
(40,000) |
1,323,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-04-01 |
4 |
AS |
$24.02 |
$960,800 |
D/D |
(40,000) |
1,278,031 |
0 |
- |
|
376 Records found
|
|
Page 14 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
